DRJ
Company Details
Linkedin ID:
drug-research-journal
Employees number:
None employees
Number of followers:
80
NAICS:
511
Industry Type:
Homepage:
thieme.de
IP Addresses:
0
Company ID:
DRU_1506523
Scan Status:
In-progress
Drug Research Journal Company CyberSecurity Posture
thieme.de
Drug Research is an international peer-reviewed Thieme journal. It publishes the latest research results related to novel and established drug molecules and the evaluation of new drug development. A key focus of the publication is translational medicine and the application of biological discoveries in the development of drugs for use in the clinical environment. Drug Research accepts original research papers and reviews with a strong emphasis on originality and scientific quality.
Drug Research Journal A.I CyberSecurity Scoring
DRJ Risk Score (AI oriented)Between 750 and 799
DRJ
Updated:
- Powered by our proprietary A.I cyber incident model
- Insurance preferes TPRM score to calculate premium
DRJ Global Score (TPRM)XXXX
DRJ
- Instant access to detailed risk factors
- Benchmark vs. industry & size peers
- Vulnerabilities
- Findings
DRJ Company CyberSecurity News & History
Past Incidents
0
Attack Types
0
No data available
DRJ Company Scoring based on AI Models
Cyber Incidents Likelihood 3 - 6 - 9 months
A.I Risk Score Likelihood 3 - 6 - 9 months
Underwriter Stats for DRJ
Incidents vs Book and Periodical Publishing Industry Average (This Year)
No incidents recorded for Drug Research Journal in 2025.
Incidents vs All-Companies Average (This Year)
No incidents recorded for Drug Research Journal in 2025.
Incident Types DRJ vs Book and Periodical Publishing Industry Avg (This Year)
No incidents recorded for Drug Research Journal in 2025.
Incident History — DRJ (X = Date, Y = Severity)
DRJ cyber incidents detection timeline including parent company and subsidiaries
DRJ Company Subsidiaries
Drug Research is an international peer-reviewed Thieme journal. It publishes the latest research results related to novel and established drug molecules and the evaluation of new drug development. A key focus of the publication is translational medicine and the application of biological discoveries in the development of drugs for use in the clinical environment. Drug Research accepts original research papers and reviews with a strong emphasis on originality and scientific quality.
Loading...
DRJ Similar Companies
SARquavitae
SARquavitae, personas que cuidan a las personas SARquavitae es la mayor plataforma de España de servicios sanitarios y sociales de atención a las personas. La plantilla, formada por 12.200 profesionales, ofrece más de 10.900 plazas repartidas por todo el territorio español y atiende a unas 200.0
Ardent Health is a leading provider of healthcare in communities across the country. With a focus on consumer-friendly processes and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, Ardent owns an
For more than 100 years, Children’s Healthcare of Atlanta has depended on clinical and nonclinical employees to help make kids better today and healthier tomorrow. Consistently ranked as one of the leading pediatric healthcare systems in the country by U.S. News & World Report, Children’s is the onl
DaVita means “to give life,” reflecting our proud history as leaders in dialysis—an essential, life-sustaining treatment for those living with end stage kidney disease (ESKD). Today, our mission is to minimize the devastating impacts of kidney disease across the full spectrum of kidney health care.
SSM Health is a Catholic, not-for-profit, fully integrated health system dedicated to advancing innovative, sustainable, and compassionate care for patients and communities throughout the Midwest and beyond. The organization’s 40,000 team members and 13,900 providers are committed to fulfilling SSM
Geisinger is among the nation’s leading providers of value-based care, serving 1.2 million people in urban and rural communities across Pennsylvania. Founded in 1915 by philanthropist Abigail Geisinger, the nonprofit system generates $10 billion in annual revenues across 126 care sites — including 1
.png)
DRJ CyberSecurity News
November 18, 2025 08:00 AM
The Complete List of Hacker And Cybersecurity Movies
Hacker's Movie Guide” with Foreword by Steve Wozniak, co-founder of Apple.
November 09, 2025 08:00 AM
Global Cybercrime Damages Predicted To Reach $6 Trillion Annually By 2021
Cybersecurity Ventures predicts cybercrime damages will cost the world $6 trillion annually by 2021, up from $3 trillion in 2015.
October 27, 2025 04:06 PM
AI in Healthcare: An Asset or Attack Surface?
Artificial intelligence (AI) has rapidly moved from experimental innovation to mainstream enterprise adoption. From predictive analytics in finance to.
October 27, 2025 07:00 AM
Muji Online Stores Taken Offline After Ransomware Attack on Logistics Partner Askul
Japanese minimalist retailer Muji was forced to shut down its online stores after a ransomware attack hit its logistics partner, Askul,...
October 23, 2025 07:00 AM
Top 5 Cybersecurity Facts, Figures, Predictions, And Statistics For 2020 To 2021
Cybercrime Magazine extrapolates the top 5 market data points from our research in order to summarize the cybersecurity industry through 2021.
October 15, 2025 07:00 AM
11 Quantum Computing Applications & Examples to Know
From cybersecurity to pharmaceutical research to finance, here are some ways quantum computing facilitates major advancements.
September 24, 2025 07:00 AM
Cybersecurity in Service Provider Selection and Qualification: A Critical Aspect of Modern Clinical Research
As clinical research becomes increasingly digital, integrating rigorous cybersecurity assessments into CRO selection and qualification is...
August 25, 2025 07:00 AM
Ransomware Attack Hits Drug Research Firm Inotiv, Disrupts Operations, and Leaks Data
A ransomware attack has forced drug research firm Inotiv to shut down critical systems, resulting in operational disruptions.
August 18, 2025 07:00 AM
Inotiv’s Business Operations Disrupted by Cybersecurity Incident
Inotiv Inc. said a cybersecurity incident earlier this month has disrupted certain business operations at the company.
Frequently Asked Questions
Explore insights on cybersecurity incidents, risk posture, and Rankiteo's assessments.
DRJ CyberSecurity History Information
Official Website of Drug Research Journal
The official website of Drug Research Journal is https://www.thieme.de/de/arzneimittelforschung-drug-research/journal-information-4521.htm.
Drug Research Journal’s AI-Generated Cybersecurity Score
According to Rankiteo, Drug Research Journal’s AI-generated cybersecurity score is 753, reflecting their Fair security posture.
How many security badges does Drug Research Journal’ have ?
According to Rankiteo, Drug Research Journal currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.
Does Drug Research Journal have SOC 2 Type 1 certification ?
According to Rankiteo, Drug Research Journal is not certified under SOC 2 Type 1.
Does Drug Research Journal have SOC 2 Type 2 certification ?
According to Rankiteo, Drug Research Journal does not hold a SOC 2 Type 2 certification.
Does Drug Research Journal comply with GDPR ?
According to Rankiteo, Drug Research Journal is not listed as GDPR compliant.
Does Drug Research Journal have PCI DSS certification ?
According to Rankiteo, Drug Research Journal does not currently maintain PCI DSS compliance.
Does Drug Research Journal comply with HIPAA ?
According to Rankiteo, Drug Research Journal is not compliant with HIPAA regulations.
Does Drug Research Journal have ISO 27001 certification ?
According to Rankiteo,Drug Research Journal is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.
Industry Classification of Drug Research Journal
Drug Research Journal operates primarily in the Book and Periodical Publishing industry.
Number of Employees at Drug Research Journal
Drug Research Journal employs approximately None employees people worldwide.
Subsidiaries Owned by Drug Research Journal
Drug Research Journal presently has no subsidiaries across any sectors.
Drug Research Journal’s LinkedIn Followers
Drug Research Journal’s official LinkedIn profile has approximately 80 followers.
NAICS Classification of Drug Research Journal
Drug Research Journal is classified under the NAICS code 511, which corresponds to Publishing Industries (except Internet).
Drug Research Journal’s Presence on Crunchbase
No, Drug Research Journal does not have a profile on Crunchbase.
Drug Research Journal’s Presence on LinkedIn
Yes, Drug Research Journal maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/drug-research-journal.
Cybersecurity Incidents Involving Drug Research Journal
As of November 28, 2025, Rankiteo reports that Drug Research Journal has not experienced any cybersecurity incidents.
Number of Peer and Competitor Companies
Drug Research Journal has an estimated 4,881 peer or competitor companies worldwide.
Drug Research Journal CyberSecurity History Information
How many cyber incidents has Drug Research Journal faced ?
Total Incidents: According to Rankiteo, Drug Research Journal has faced 0 incidents in the past.
What types of cybersecurity incidents have occurred at Drug Research Journal ?
Incident Types: The types of cybersecurity incidents that have occurred include .
Incident Details
What are the most common types of attacks the company has faced ?
Additional Questions
.png)
Latest Global CVEs (Not Company-Specific)
Description
ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.
Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description
Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).
Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
References
Description
Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint
Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
References
Description
Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.
Description
Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.
Access Data Using Our API
Get company history
curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?linkedin_id=drug-research-journal' -H 'apikey: YOUR_API_KEY_HERE'
RapidWhat Do We Measure ?
Incident
Finding
Grade
Digital Assets
Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.
These are some of the factors we use to calculate the overall score:
Network Security
Identify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.
SBOM (Software Bill of Materials)
Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.
CMDB (Configuration Management Database)
Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.
Threat Intelligence
Leverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.
Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.
